r21442
12 Jan 2018
Re: iii price An embarrassment to iii if you ask me. Couldn't understand it myself. Losing much faith in this 'platform'. Huge jump for my portfolio. Had never given up on LRM and now stand to make a tidy return.
jim b-r
11 Jan 2018
Re: iii price Errr ... in case you missed it: recommended cash offer at 13p per share!
Mr Papillon
11 Jan 2018
Re: iii price What the future has happened?
IB Investor
11 Jan 2018
iii price this is rather disappointing the price has doubled today, yet the price on iii has fall
IB Investor
01 Nov 2017
news Surprised this has not rebounded - good news of a new deal and analysis saying deals have been pushed back into the next financial period - a common problem with software companies where income tends to come in lumpy contracts. This happened about a year ago, and the share price staged a strong recovery
r21442
30 Oct 2017
Re: IC: Simon Thompson view on H1 results Today's article in same...Disappointing first half results from Lombard Risk Management (LRM:7p), a provider of collateral management and regulatory reporting software products to clients including 30 of the top 50 global banks, hedge funds and asset managers, led to a 30 per cent mark down in its share price, taking it well below the 10.5p level at which I last advised buying at (‘A five-timer of small-cap plays’, 24 Jul 2017), and also my original 9p entry point ('Banking on regulation', 13 Mar 2017).Longer lead times for deals to be concluded for Lombard’s AGILREPORTER regulatory reporting product which is being sold in partnership with Oracle, and an overreliance on North America which has since been addressed, were compounded by some slippage on clients committing to major software investments ahead of the introduction of the new MIFID II regulations in early January. This resulted in first-half revenues contracting by 16 per cent to £13.7m. And because the company had increased its cost base, reflecting investment in sales staff and a new facility in Birmingham, then given the scale of the revenue shortfall for what is a highly operationally geared business, this meant that cash profits of £1.5m in the first half last year reversed into a £3.5m cash loss. In turn, Lombard’s net cash position declined from £7m to £400,000, albeit it has £4.5m of untapped debt facilities in place. It’s understandable that investors reacted negatively.However, broking house finnCap didn’t downgrade their full-year expectations which point to revenues rising 16 per cent to £40m in the 12 months to end March 2018 to produce cash profits of £6.6m, implying a 42 per cent increase in second half revenues to £27.3m. That’s because chief executive Alastair Brown and finance director Nigel Gurney informed me during our results call that the order pipeline of over 120 opportunities is well in excess of £40m, a record level and up 44 per cent since March 2017, Lombard started the second half with an order backlog of £9.2m, and recurring revenue of £6.4m is due to be delivered in the second half.The two insiders also said that two contracts for Lombard’s compliance software product COLLINE, worth a total of £5m in license fees alone, are expected to be signed in the coming months. Lombard is the sole vendor in contention on the larger of these contracts, worth £3.25m, and the client on the other is targeting “implementation in January”. The cash flow from these contracts would boost Lombard’s cash position no end – analysts at Equity Development are forecasting net funds of £5.5m at the March 2018 year-end – and de-risk full-year profit estimates too. Although analysts at Equity Development and N+1 Singer clipped their full-year revenue by £2m, this still points towards full-year cash profits rising by 88 per cent plus to £4.5m and £4.9m, respectively, implying Lombard’s market value of £28m represents less than six times forecast cash profits.The other key take for me was that Lombard closed its first contract with an Australian client in advance of the new Prudential Regulatory Authority regulations coming into force in the country. Given the similarity in the regulatory framework between the UK and Australia, this offers a huge opportunity for it to win more contracts.So, although the seasonal second half bias to forecasts has increased markedly, the directors remain confident of delivering on their record pipeline, the successful execution and accompanying cash flow from which should support a reversal of last week’s hefty losses. I would flag up too that the shares are massively oversold with the 14-day RSI on the floor. Trading buy.
NeroHadsi
27 Oct 2017
ST Vs. TW Who will prove to be right?
jim b-r
26 Oct 2017
IC: Simon Thompson view on H1 results "The mark down in Lombard's share price today looks a massive overreaction. finncap and N+1 Singer have not downgraded their forecasts. True, the second half bias to the numbers has increased but they stil expect revenues to rise from £34m to £40m for the full year and the company to deliver a £4m rise in cash profits to £6.6m. Also, the directors are "confident of this being achieved." I also understand that two COLLINE contracts, worth £3.25m and £1.7m, respectively, in license fees alone, are expected to be signed in the coming months. The cash from this will boost the net funds position back to £5.5m.Moreover, the order pipeline of over 120 opportunities is well in excess of £40m, a record level and up 44 per cent since March 2017, Lombard started the second half with an order backlog of £9.2m, and recurring revenue of £6.4m is due to be delivered in the second half.Clearly, the second half bias to the numers has risen, but if Lombard delivers - and £15.6m of the second half revenue estimate of £27.3m is recurring revenue and the order backlog alone - then the share price is going to reverse today's losses. I see the shares as a trading buy at 7.25p.RegardsSimon"
Mr Papillon
13 Oct 2017
Price Manipulation It's amazing isn't it. This share has risen or dropped every day yet opens at the same price ever day.
Carefully Does It
12 Oct 2017
Position Have been buying.
Mr Papillon
21 Sep 2017
RNS today Canacord Genuity (Canada) takes an 8% stake in Lombard Risk Management. They must be confident.
Mr Papillon
27 Jul 2017
Todays RNS Seems like a good partnerhsip. I can see potential merger or acquisition in the offing on this one.
r21442
19 Jul 2017
Re: Have Read RNS - So why the huge drop Suspect some folks were gambling on more than the RNS statement of continuance and regular trading pattern? It was kind of muted statement tbf?
IB Investor
19 Jul 2017
Re: Have Read RNS - So why the huge drop Nope this share has been all over the place this year. I sold a few months ago after 12 years - made some money in the interim buying and selling, but the price has not move much over that time - often i dont understand the fluctuations - got back in a few weeks ago, but now at a loss.
Mr Papillon
19 Jul 2017
Have Read RNS - So why the huge drop I don't understand why there has been such a huge drop in SP when the RNS is hardly negative.Any clues?
